CINQAIR (reslizumab)

Cinqair – Medicines such as CINQAIR reduce blood eosinophils. Eosinophils are a type of white blood cell that may contribute to your asthma. CINQAIR is not used to treat other problems caused by eosinophils. CINQAIR is not used to treat sudden breathing problems.

Teva Announces FDA Approval of CINQAIR® (reslizumab) Injection

Information about CINQAIR® (reslizumab) Injection for patients

8080 Ravines Edge Court Columbus, Ohio 43235